scispace - formally typeset
M

Michael Goggins

Researcher at Johns Hopkins University

Publications -  378
Citations -  52451

Michael Goggins is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Pancreatic cancer & Cancer. The author has an hindex of 111, co-authored 358 publications receiving 45785 citations. Previous affiliations of Michael Goggins include Johns Hopkins University School of Medicine & Fred Hutchinson Cancer Research Center.

Papers
More filters
Journal ArticleDOI

Circulating Tumor Cells Expressing Markers of Tumor Initiating Cells Predict Poor Survival and Cancer Recurrence in Patients with Pancreatic Ductal Adenocarcinoma.

TL;DR: CTCs labeling with one or more markers of TICs are found in a majority of patients with PDAC and are independently predictive of decreased disease-free and overall survival.
Journal ArticleDOI

The genetics of FANCC and FANCG in familial pancreatic cancer.

TL;DR: The role of germline FA gene mutations in kindred in which several family members had pancreatic cancer is determined and published data suggest the possibility that although germline and somatic mutations in FANCC and FANCG may contribute to the occurrence of pancreatic cancers, the Pancreatic cancers that arise do so in an apparent sporadic fashion rather than with a phenotype of familial pancreaticcancer.
Journal ArticleDOI

Transmission of a T-cell lymphoma by allogeneic bone marrow transplantation.

TL;DR: A 19-year-old woman with an aggressive lymphoma received a bone marrow transplant from her sister three and a half years later subcutaneous panniculitic T-cell lymphoma was diagnosed in the donor; the same rare tumor appeared in the recipient four and ahalf years after transplantation.
Journal ArticleDOI

Pancreatic cancer associated fibroblasts display normal allelotypes.

TL;DR: P53 protein expression was confined to invasive pancreatic adenocarcinoma cells and was not expressed in cancer-associated fibroblasts, finding no evidence that pancreatic cancer associated fibro Blasts harbor somatic copy number changes or immunohistochemical evidence of p53 mutations.
Journal ArticleDOI

Progress in Cancer Genetics: Lessons From Pancreatic Cancer

TL;DR: Further advances in pancreatic cancer molecular genetics are needed to facilitate the development of molecular screening tests, to identify additional familial susceptibility genes, and to identify targets for rational therapeutic targeting.